The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Naringenin: A potential flavonoid phytochemical for cancer therapy
Abstract
Naringenin is an important phytochemical which belongs to the flavanone group of polyphenols, and is found mainly in citrus fruits like grapefruits and others such as tomatoes and cherries plus medicinal plants derived food. Available evidence demonstrates that naringenin, as herbal medicine, has important pharmacological properties, including anti-inflammatory, antioxidant, neuroprotective, hepatoprotective, and anti-cancer activities. Collected data from in vitro and in vivo studies show the inactivation of carcinogens after treatment with pure naringenin, naringenin-loaded nanoparticles, and also naringenin in combination with anticancer agents in various malignancies, such as colon cancer, lung neoplasms, breast cancer, leukemia and lymphoma, pancreatic cancer, prostate tumors, oral squamous cell carcinoma, liver cancer, brain tumors, skin cancer, cervical and ovarian cancer, bladder neoplasms, gastric cancer, and osteosarcoma. Naringenin inhibits cancer progression through multiple mechanisms, like apoptosis induction, cell cycle arrest, angiogenesis hindrance, and modification of various signaling pathways including Wnt/β-catenin, PI3K/Akt, NF-ĸB, and TGF-β pathways. In this review, we demonstrate that naringenin is a natural product with potential for the treatment of different types of cancer, whether it is used alone, in combination with other agents, or in the form of the naringenin-loaded nanocarrier, after proper technological encapsulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
RETRACTED: Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms
Slika, H., Mansour, H., Wehbe, N., Nasser, S. A., Iratni, R., Nasrallah, G., Shaito, A., Ghaddar, T., Kobeissy, F., & Eid, A. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112442 · Cited by 441
RetractedShi, X., Luo, X., Chen, T., Guo, W., Liang, C., Tang, S., & Mo, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16226 · Cited by 71
RetractedLian, G., Wang, Q., Mak, T. S., Huang, X., Yu, X., & Lan, H. Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.01.006 · Cited by 70
RetractedWang, R., Wang, J., Dong, T., Shen, J., Gao, X., & Zhou, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9704 · Cited by 57
RetractedParashar, P., Tripathi, C. B., Arya, M., Kanoujia, J., Singh, M. V., Yadav, A. K., Kumar, A., Guleria, A., & Saraf, S. A. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1505738 · Cited by 30
RetractedRETRACTED ARTICLE: Plausible role of naringenin against cerebrally implanted C6 glioma cells in rats
Sabarinathan, D., & Vanisree, A. J. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1539-9 · Cited by 11
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Colorectal cancer statistics, 2020
Siegel, R. L., Miller, K. D., Goding Sauer, A., Fedewa, S. A., Butterly, L. F., Anderson, J. C., Cercek, A., Smith, R. A., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21601 · Cited by 4,880
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Lenis, A. T., Lec, P. M., Chamie, K., & MSHS, M. (2020) · JAMA · doi:10.1001/jama.2020.17598 · Cited by 2,051
Erlund, I. (2004) · Nutrition Research · doi:10.1016/j.nutres.2004.07.005 · Cited by 927
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
Cumberbatch, M. G. K., Jubber, I., Black, P. C., Esperto, F., Figueroa, J. D., Kamat, A. M., Kiemeney, L., Lotan, Y., Pang, K., Silverman, D. T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.001 · Cited by 820
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
Dochez, V., Caillon, H., Vaucel, E., Dimet, J., Winer, N., & Ducarme, G. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0503-7 · Cited by 577
A review on biosynthesis of metal nanoparticles and its environmental applications
Saravanan, A., Kumar, P. S., Karishma, S., Vo, D.-V. N., Jeevanantham, S., Yaashikaa, P. R., & George, C. S. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.128580 · Cited by 554
Vu, M., Yu, J., Awolude, O. A., & Chuang, L. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.003 · Cited by 548
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Dietary Flavonoids as Cancer Chemopreventive Agents: An Updated Review of Human Studies
Rodríguez-García, C., Sánchez-Quesada, C., & Gaforio, J. J. (2019) · Antioxidants · doi:10.3390/antiox8050137 · Cited by 360
Targeting Inflammation in Cancer Prevention and Therapy
Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 354
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández-Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 347
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Self-citationEpidemiology and Etiology of Leukemia and Lymphoma
Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034819 · Cited by 319
Osteosarcoma: a review of current and future therapeutic approaches
Zhao, X., Wu, Q., Gong, X., Liu, J., & Ma, Y. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00860-0 · Cited by 312
Naringenin as a potential immunomodulator in therapeutics
Zeng, W., Jin, L., Zhang, F., Zhang, C., & Liang, W. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.002 · Cited by 305
Nahmias, Y., Goldwasser, J., Casali, M., van Poll, D., Wakita, T., Chung, R. T., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22197 · Cited by 279
Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
Joshi, R., Kulkarni, Y. A., & Wairkar, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.066 · Cited by 278
Review of Natural Compounds for Potential Skin Cancer Treatment
Chinembiri, T., Du Plessis, L., Gerber, M., Hamman, J., & Du Plessis, J. (2014) · Molecules · doi:10.3390/molecules190811679 · Cited by 270
Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
Den Hartogh, D. J., & Tsiani, E. (2019) · Biomolecules · doi:10.3390/biom9030099 · Cited by 267
Combating oxidative stress disorders with citrus flavonoid: Naringenin
Zaidun, N. H., Thent, Z. C., & Latiff, A. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.017 · Cited by 265
Tutunchi, H., Naeini, F., Ostadrahimi, A., & Hosseinzadeh‐Attar, M. J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6781 · Cited by 255
Epidemiology and Risk Factors of Osteosarcoma
Sadykova, L. R., Ntekim, A. I., Muyangwa-Semenova, M., Rutland, C. S., Jeyapalan, J. N., Blatt, N., & Rizvanov, A. A. (2020) · Cancer Investigation · doi:10.1080/07357907.2020.1768401 · Cited by 237
Kanno, S.-I., Tomizawa, A., Hiura, T., Osanai, Y., Shouji, A., Ujibe, M., Ohtake, T., Kimura, K., & Ishikawa, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.527 · Cited by 233
Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., & Goel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057218 · Cited by 226
Self-citationNaringenin and naringin in cardiovascular disease prevention: A preclinical review
Heidary Moghaddam, R., Samimi, Z., Moradi, S. Z., Little, P. J., Xu, S., & Farzaei, M. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173535 · Cited by 219
Memariani, Z., Abbas, S. Q., ul Hassan, S. S., Ahmadi, A., & Chabra, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105264 · Cited by 213
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
Bhia, M., Motallebi, M., Abadi, B., Zarepour, A., Pereira-Silva, M., Saremnejad, F., Santos, A. C., Zarrabi, A., Melero, A., Jafari, S. M., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020291 · Cited by 202
Self-citationArul, D., & Subramanian, P. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9641-1 · Cited by 179
Ahamad, M. S., Siddiqui, S., Jafri, A., Ahmad, S., Afzal, M., & Arshad, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110003 · Cited by 177
(2004) · Seminars in Oncology Nursing · doi:10.1053/s0749-2081(04)00049-x · Cited by 177
Wu, C., Ji, P., Yu, T., Liu, Y., Jiang, J., Xu, J., Zhao, Y., Hao, Y., Qiu, Y., & Zhao, W. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s97738 · Cited by 175
Nouri, Z., Fakhri, S., El-Senduny, F. F., Sanadgol, N., Abd-ElGhani, G. E., Farzaei, M. H., & Chen, J.-T. (2019) · Biomolecules · doi:10.3390/biom9110690 · Cited by 168
Arafah, A. M., Rehman, M. U., Mir, T. M., Wali, A. F., Ali, R., Qamar, W., Khan, R., Ahmad, A., Aga, S. S., Alqahtani, S., et al. (2020) · Plants · doi:10.3390/plants9121784 · Cited by 168
Lim, W., Park, S., Bazer, F. W., & Song, G. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25729 · Cited by 166
Shakibaei, M., Kraehe, P., Popper, B., Shayan, P., Goel, A., & Buhrmann, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1291-0 · Cited by 158
Self-citationHarmon, A. W., & Patel, Y. M. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000025397.56192.e2 · Cited by 153
Zhao, Z., Jin, G., Ge, Y., & Guo, Z. (2019) · Inflammopharmacology · doi:10.1007/s10787-018-00556-3 · Cited by 150
Chemopreventive and Therapeutic Potential of “Naringenin,” a Flavanone Present in Citrus Fruits
Mir, I. A., & Tiku, A. B. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2015.976320 · Cited by 146
Kumar, S. P., Birundha, K., Kaveri, K., & Devi, K. T. R. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.03.045 · Cited by 142
Karim, N., Jia, Z., Zheng, X., Cui, S., & Chen, W. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.06.012 · Cited by 137
Bao, L., Liu, F., Guo, H., Li, Y., Tan, B., Zhang, W., & Peng, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5013-2 · Cited by 133
Parashar, P., Rathor, M., Dwivedi, M., & Saraf, S. A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010033 · Cited by 133
Abaza, M. S. I., Orabi, K. Y., Al-Quattan, E., & Al‐Attiyah, R. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0194-0 · Cited by 130
Frydoonfar, H. R., McGrath, D. R., & Spigelman, A. D. (2003) · Colorectal Disease · doi:10.1046/j.1463-1318.2003.00444.x · Cited by 130
Bouzaiene, N. N., Chaabane, F., Sassi, A., Ghédira, L. C., & Ghédira, K. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.11.030 · Cited by 129
The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells
Gao, K., Henning, S. M., Niu, Y., Youssefian, A. A., Seeram, N. P., Xu, A., & Heber, D. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.05.009 · Cited by 128
Leonardi, T., Vanamala, J., Taddeo, S. S., Davidson, L. A., Murphy, M. E., Patil, B. S., Wang, N., Carroll, R. J., Chapkin, R. S., Lupton, J. R., et al. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009359 · Cited by 128
Choi, J., Lee, D.-H., Jang, H. J., Park, S., & Seol, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.44804 · Cited by 124
Shi, J., Liu, F., ZHANG, W., Liu, X., Lin, B., & Tang, X. (2015) · Oncology Reports · doi:10.3892/or.2015.3889 · Cited by 123
Krishnakumar, N., Sulfikkarali, N., Prasad, N. R., & Karthikeyan, S. (2011) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2011.09.003 · Cited by 120
Lou, C., Zhang, F., Yang, M., Zhao, J., Zeng, W., Fang, X., Zhang, Y., Zhang, C., & Liang, W. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050956 · Cited by 118
Naringenin reduces lung metastasis in a breast cancer resection model
Qin, L., Jin, L., Lu, L., Lu, X., Zhang, C., Zhang, F., & Liang, W. P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1056-8 · Cited by 118
Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent
Rauf, A., Shariati, M. A., Imran, M., Bashir, K., Khan, S. A., Mitra, S., Emran, T. B., Badalova, K., Uddin, M. S., Mubarak, M. S., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-18754-6 · Cited by 118
Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine Degradation
Jin, L., Zeng, W., Zhang, F., Zhang, C., & Liang, W. P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602016 · Cited by 113
Totta, P., Acconcia, F., Leone, S., Cardillo, I., & Marino, M. (2004) · IUBMB Life · doi:10.1080/15216540400010792 · Cited by 110
Md, S., Alhakamy, N. A., Aldawsari, H. M., Husain, M., Kotta, S., Abdullah, S., Fahmy, U. A., Alfaleh, M. A., & Asfour, H. Z. (2020) · Pharmaceuticals · doi:10.3390/ph13070152 · Cited by 110
Park, J. H., Jin, C., Lee, B. K., Kim, G., Choi, Y. H., & Jeong, Y. K. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.09.056 · Cited by 108
Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma
He, S., Chakraborty, R., & Ranganathan, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031562 · Cited by 106
Cipolletti, M., Fernandez, V. S., Montalesi, E., Marino, M., & Fiocchetti, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092624 · Cited by 104
Park, H. J., Choi, Y. J., Lee, J. H., & Nam, M. J. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.11.008 · Cited by 103
Nyane, N. A., Tlaila, T. B., Malefane, T. G., Ndwandwe, D. E., & Owira, P. M. O. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.042 · Cited by 101
New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis
Chen, S., Hsiao, S., Chang, K., & Chang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052252 · Cited by 98
Jin, C., Park, C., Hwang, H. J., Kim, G., Choi, B. T., Kim, W., & Choi, Y. H. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000024 · Cited by 97
Zhang, F., Dong, W., Zeng, W., Zhang, L., Zhang, C., Qiu, Y., Wang, L., Yin, X., Zhang, C., & Liang, W. P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0698-0 · Cited by 97
Zhang, F. Y., Du, G. J., Zhang, L., Zhang, C. L., Lü, W.-L., & Liang, W. P. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9793-y · Cited by 96
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
Iida, K., Naiki, T., Naiki‐Ito, A., Suzuki, S., Kato, H., Nozaki, S., Nagai, T., Etani, T., Nagayasu, Y., Ando, R., et al. (2020) · Cancer Science · doi:10.1111/cas.14334 · Cited by 92
Lian, G., Wang, Q., Tang, P. M., Zhou, S. Y., Huang, X., & Lan, H.-Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.016 · Cited by 86
Lee, J., Kim, D., & Kim, J. H. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.022 · Cited by 86
Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies
Iriti, M., & Varoni, E. M. (2013) · Nutrients · doi:10.3390/nu5072564 · Cited by 83
Yen, H., Liu, C.-J., & Yeh, C.-C. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.003 · Cited by 83
Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
Fuster, M. G., Carissimi, G., Montalbán, M. G., & Víllora, G. (2020) · Nanomaterials · doi:10.3390/nano10040718 · Cited by 82
Bodduluru, L. N., Kasala, E. R., Madhana, R. M., Barua, C. C., Hussain, M. I., Haloi, P., & Borah, P. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.11.036 · Cited by 81
Buhrmann, C., Shayan, P., Banik, K., Kunnumakkara, A. B., Kubatka, P., Koklesová, L., & Shakibaei, M. (2020) · Biomedicines · doi:10.3390/biomedicines8080236 · Cited by 80
Self-citationCurcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Liao, H., Wang, Z., Deng, Z., Ren, H., & Li, X. (2015) · Europe PMC (PubMed Central) · Cited by 79
Kanno, S., Tomizawa, A., Ohtake, T., Koiwai, K., Ujibe, M., & Ishikawa, M. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.06.005 · Cited by 78
Sulfikkarali, N., Krishnakumar, N., Manoharan, S., & Nirmal, R. M. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9581-1 · Cited by 77
Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels
Aktas, H. G., & Akgun, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.008 · Cited by 77
Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease
VoPham, T. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-0183-2 · Cited by 77
Naeini, F., Namkhah, Z., Ostadrahimi, A., Tutunchi, H., & Hosseinzadeh‐Attar, M. J. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa106 · Cited by 75
Nanotechnology for delivery of natural therapeutic substances: a review
Saka, R., & Chella, N. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01103-9 · Cited by 74
Buhrmann, C., Shayan, P., Brockmueller, A., & Shakibaei, M. (2020) · Molecules · doi:10.3390/molecules25184292 · Cited by 73
Self-citationPerspective: The Potential Effects of Naringenin in COVID-19
Alberca, R. W., Teixeira, F. M. E., Beserra, D. R., de Oliveira, E. A., Andrade, M. M. D. S., Pietrobon, A. J., & Sato, M. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570919 · Cited by 73
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
Yang, Y., Li, N., Wang, T., & Di, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910827 · Cited by 71
Mendes, L. A. D. O., Ponciano, C. S., Cataneo, A. H. D., Wowk, P. F., Bordignon, J., Silva, H., de Almeida, M. V., & Ávila, E. P. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109218 · Cited by 69
Molecular mechanisms of action of naringenin in chronic airway diseases
Chin, L. H., Hon, C. M., Chellappan, D. K., Chellian, J., Madheswaran, T., Zeeshan, F., Awasthi, R., Aljabali, A. A. A., Tambuwala, M. M., Dureja, H., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173139 · Cited by 68
Stompor, M., Uram, Ł. S., & Podgórski, R. (2017) · Molecules · doi:10.3390/molecules22071092 · Cited by 66
Wesołowska, O., Wiśniewski, J. Ł., Środa-Pomianek, K., Bielawska‐Pohl, A., Paprocka, M., Duś, D., Duarte, N., Ferreira, M. U., & Michalak, K. (2012) · Journal of Natural Products · doi:10.1021/np3003468 · Cited by 65
Bulzomi, P., Bolli, A., Galluzzo, P., Acconcia, F., Ascenzi, P., & Marino, M. (2012) · IUBMB Life · doi:10.1002/iub.1049 · Cited by 65
Sahrayi, H., Hosseini, E., Karimifard, S., Khayam, N., Meybodi, S. M., Amiri, S., Bourbour, M., Far, B. F., Akbarzadeh, I., Bhia, M., et al. (2021) · Pharmaceuticals · doi:10.3390/ph15010006 · Cited by 65
Self-citationKoçyiğit, A., Koyuncu, İ., Dikilitaş, M., Bahadorı, F., & Türkkan, B. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.08.004 · Cited by 64
Raeisi, S., Chavoshi, H., Mohammadi, M., Ghorbani, M., Sabzichi, M., & Ramezani, F. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.05.013 · Cited by 64
Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells
Zhang, H., Zhong, X., Zhang, X., Shang, D., ZHOU, Y., & Zhang, C. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2912 · Cited by 63
Sangpheak, W., Kicuntod, J., Schuster, R., Rungrotmongkol, T., Wolschann, P., Kungwan, N., Viernstein, H., Mueller, M., & Pongsawasdi, P. (2015) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.11.297 · Cited by 63
Song, H. M., Park, G. H., Eo, H. J., Lee, J. W., Kim, M. K., Lee, J. R., Lee, M. H., Koo, J. S., & Jeong, J. B. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.024 · Cited by 61
Naringenin-Mediated ATF3 Expression Contributes to Apoptosis in Human Colon Cancer
Song, H. M., Park, G. H., Eo, H. J., & Jeong, J. B. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.109 · Cited by 61
Huang, Y., Yang, C., & Chiou, Y.-L. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.06.028 · Cited by 59
Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer
Miyata, Y., Matsuo, T., Araki, K., Nakamura, Y., Sagara, Y., Ohba, K., & Sakai, H. (2018) · Medicines · doi:10.3390/medicines5030087 · Cited by 59
Akhter, M. H., Kumar, S., & Nomani, S. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1747485 · Cited by 57
Hatkevich, T., Ramos, J., Santos-Sanchez, I., & Patel, Y. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.05.017 · Cited by 56
Lee, E.-R., Kang, Y.-J., Choi, H.-Y., Kang, G., Kim, J., Kim, B., Han, Y. S., Nah, S.-Y., Paik, H., Park, Y.-S., et al. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2394 · Cited by 56
Morais, R. P., Novais, G. B., Sangenito, L. S., dos Santos, A. L. S., Priefer, R., Morsink, M. A. J., Mendonça, M. D. C., Souto, E. B., Severino, P. B., & Cardoso, J. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124557 · Cited by 56
Naringenin and 17β‐estradiol coadministration prevents hormone‐induced human cancer cell growth
Bulzomi, P., Bolli, A., Galluzzo, P., Leone, S., Acconcia, F., & Marino, M. (2009) · IUBMB Life · doi:10.1002/iub.279 · Cited by 55
6-C-(E-phenylethenyl)-Naringenin Suppresses Colorectal Cancer Growth by Inhibiting Cyclooxygenase-1
Li, H., Zhu, F., Chen, H., Cheng, K., Zykova, T. A., Oi, N., Lubet, R. A., Bode, A. M., Wang, M., & Dong, Z. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2245 · Cited by 55
Noori, S., Tavirani, M. R., Deravi, N., Rabbani, M. I. M., & Zarghi, A. (2020) · Iranian journal of pharmaceutical research · doi:10.22037/ijpr.2020.113103.14112 · Cited by 54
Myricetin and Naringenin Inhibit Human Squamous Cell Carcinoma Proliferation and Migration In Vitro
Maggioni, D., Nicolini, G., Rigolio, R., Biffi, L., Pignataro, L., Gaini, R. M., & Garavello, W. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.951732 · Cited by 53
Bak, Y., Kim, H., Kang, J.-W., Lee, D. H., Kim, M. S., Park, Y. S., Kim, J. H., Jung, K., Lim, Y., Hong, J. T., et al. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2017594 · Cited by 52
Stimulation of Melanogenesis by the Citrus Flavonoid Naringenin in Mouse B16 Melanoma Cells
Ohguchi, K., Akao, Y., & Nozawa, Y. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.50635 · Cited by 52
Rajamani, S., Radhakrishnan, A., Sengodan, T., & Thangavelu, S. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1496445 · Cited by 51
Hermawan, A., Ikawati, M., Jenie, R. I., Khumaira, A., Putri, H., Nurhayati, I. P., Angraini, S. M., & Muflikhasari, H. A. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.12.002 · Cited by 49
Food components and contaminants as (anti)androgenic molecules
Marcoccia, D., Pellegrini, M., Fiocchetti, M., Lorenzetti, S., & Marino, M. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0555-5 · Cited by 47
Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level
Zhang, C., Zeng, W., Yao, Y., Xu, B., Wei, X., Wang, L., Yin, X., Barman, A. K., Zhang, F., Zhang, C., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248807 · Cited by 47
Pateliya, B., BURADE, V. S., & Goswami, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173725 · Cited by 46
Resveratrol and Colorectal Cancer: A Molecular Approach to Clinical Researches
Vernousfaderani, E. K., Akhtari, N., Rezaei, S., et al. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211105093658 · Cited by 46
Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats
Sabarinathan, D., Mahalakshmi, P., & Vanisree, A. J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.028 · Cited by 44
Filho, J. C. C., Sarria, A. L. F., Becceneri, A. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107058 · Cited by 44
Zhao, Y., Fan, D., Ru, B., Cheng, K., Hu, S., Zhang, J., Li, E. T. S., & Wang, M. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.001 · Cited by 44
Naringenin Induces ROS-Mediated ER Stress, Autophagy, and Apoptosis in Human Osteosarcoma Cell Lines
Lee, C., Huang, C. C., Chi, M., Lee, K., Peng, K., Fang, M.-L., Chiang, Y., & Liu, J. (2022) · Molecules · doi:10.3390/molecules27020373 · Cited by 44
Kawaguchi, S., Kawahara, K., Fujiwara, Y., Ohnishi, K., Pan, C., Yano, H., Hirosue, A., Nagata, M., Hirayama, M., Sakata, J., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03149-w · Cited by 44
Tamayo, L. V., Gouvea, L. R., Sousa, A. C., Albuquerque, R. M., Teixeira, S. F., Azevedo, R., Louro, S. R. W., Ferreira, A. K., & Beraldo, H. D. O. (2015) · BioMetals · doi:10.1007/s10534-015-9894-0 · Cited by 43
Chaurasia, S., Patel, R. R., Vure, P., & Mishra, B. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.006 · Cited by 43
Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells
Lee, E., Kang, Y., Kim, H., Choi, H., Kang, G., Kim, J., Kim, B., Jeong, H., Park, Y., & Cho, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21622 · Cited by 40
Diosmin in combination with naringenin enhances apoptosis in colon cancer cells
Zeya, B., Nafees, S., Imtiyaz, K., Uroog, L., Fakhri, K. U., & Rizvi, M. M. A. (2021) · Oncology Reports · doi:10.3892/or.2021.8215 · Cited by 39
Li, R., FENG, Y.-Q., CHEN, J.-H., GE, L.-T., Xiao, S., & Zuo, X. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2185 · Cited by 37
Kim, J. H., & Lee, J. K. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0624-5 · Cited by 36
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
Nollmann, F. I., & Ruess, D. A. (2020) · Biomedicines · doi:10.3390/biomedicines8080281 · Cited by 35
Combinatorial Antitumor Effect of Naringenin and Curcumin Elicit Angioinhibitory Activities In Vivo
Anand, K., Sarkar, A., Kumar, A., Ambasta, R. K., & Kumar, P. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.686648 · Cited by 34
Helle, J., Kräker, K., Bader, M. I., Keiler, A. M., Zierau, O., Vollmer, G., Welsh, J., & Kretzschmar, G. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.014 · Cited by 34
Chaurasia, S., Patel, R. R., Vure, P., & Mishra, B. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0436 · Cited by 33
Ganapathy, E., Rajendran, P., Rajasekaran, D., Magesh, V., & Sakthisekaran, D. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04987.x · Cited by 32
Buhrmann, C., Brockmueller, A., Harsha, C., Kunnumakkara, A. B., Kubatka, P., Aggarwal, B. B., & Shakibaei, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.699842 · Cited by 32
Self-citationKang, Q., Gong, J., Wang, M., Wang, Q., Chen, F., & Cheng, K. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05733 · Cited by 32
Eanes, L., & Patel, Y. M. (2016) · Biochimie Open · doi:10.1016/j.biopen.2016.09.004 · Cited by 30
Flavonoids regulate cell death-related cellular signaling via ROS in human colon cancer cells
Dükel, M., Tavşan, Z., & Kayalı, H. A. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.10.002 · Cited by 29
Chen, Z., Chen, P., Wu, H., Shi, R., Su, W., Wang, Y., & Li, P. (2020) · Biomolecules · doi:10.3390/biom10121644 · Cited by 28
Buhrmann, C., Kunnumakkara, A. B., Kumar, A., Samec, M., Kubatka, P., Aggarwal, B. B., & Shakibaei, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650603 · Cited by 27
Self-citationShi, D., Xu, Y., Du, X., Chen, X., Zhang, X., Lou, J., Li, M., & Zhuo, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4480 · Cited by 26
Zhang, L., Xu, X., Jiang, T., Wu, K.-Z., Ding, C., Liu, Z., Zhang, X., Yu, T., & Song, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8713263 · Cited by 26
Synthesis and Characterization of Naringenin-Loaded Chitosan-Dextran Sulfate Nanocarrier
Muralidharan, S., & Shanmugam, K. (2020) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-020-09444-2 · Cited by 25
The use of natural products in colorectal cancer drug discovery
Miura, K., Satoh, M., Kinouchi, M., Yamamoto, K., Hasegawa, Y., Kakugawa, Y., Kawai, M., Uchimi, K., Aizawa, H., Ohnuma, S., et al. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1018174 · Cited by 23
Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines
Gautam, M., & Gabrani, R. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1952438 · Cited by 20
Song, T., Zhang, M., Wu, J., Chen, F., Wang, Y. X., Ma, Y., & Dai, Z. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00979-2 · Cited by 18
BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression
Xu, J., Guo, Z., Yuan, S., & Li, H. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04389-1 · Cited by 18
Liu, J., Chang, T., Chen, P., Lin, J. S., Tsai, Y., Wu, H.-M., & Lee, C. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14221 · Cited by 17
Inhibitory effect of GB-2a (I3-naringenin-II8-eriodictyol) on melanogenesis
Campos, P. M., Prudente, A. S., Horinouchi, C. D. D. S., Filho, V. C., Fávero, G. M., Cabrini, D. A., & Otuki, M. F. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.08.015 · Cited by 16
AmeliMojarad, M., AmeliMojarad, M., Wang, J., & Noourbakhsh, M. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101532 · Cited by 10
Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma
Su, Q., Xu, X., Wang, J., Luan, J., Ren, X., Huang, H., & Bian, S.-S. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-2941-x · Cited by 9
Zhang, S., Wang, Y., Sun, Y., Zhao, G., Wang, J., Liu, L., Liu, F., Wang, P., & Xu, X. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104962 · Cited by 6
Arul, D., Subramanian, P., & Jayakumar, M. (2011) · Biological Rhythm Research · doi:10.1080/09291016.2010.526417 · Cited by 4
Arul, D., & Subramanian, P. (2011) · Biological Rhythm Research · doi:10.1080/09291016.2011.631764 · Cited by 2
Metadata
- Authors
- Motallebi, M., Bhia, M., Rajani, H. F., Bhia, I., Tabarraei, H., Mohammadkhani, N., Pereira-Silva, M., Kasaii, M. S., Nouri-Majd, S., Mueller, A.-L., Veiga, F. J. B., Paiva-Santos, A. C., & Shakibaei, M.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 305
- Pages
- 120752
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W4283705512
- Cited by
- 328
- References
- 162
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.